🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Singapore / NCT07463014
Recruiting Not applicable

Peer Enriched Environment for Recovery (PEER)

NCT07463014 · tracked via the Priya Life Science Singapore tracker
Phase
Not applicable
Started
2025-01-01
Last updated
2026-03-10

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

Peer-Enriched Environment for Recovery (PEER)

Peer-Enriched Environment for Recovery (PEER): The PEER intervention is a post-stroke peer coaching intervention. Participants who undergo this intervention will have 5 coaching sessions, which are delivered by trained peer coaches in-person. In each session, peer coaches will practice psychoeducation, experience sharing, and interactive activity, to provide intervention recipients with psychosocial support. Each coaching session will focus on a specific topic related to post-stroke recovery.

Study summary

The goal of this interventional study is to assess whether a peer coaching intervention (PEER) can improve the well-being in individuals who experienced a stroke. The main questions it aims to answer are

1. Is the PEER intervention feasible and acceptable for the intervention recipients who receive the intervention?
2. Is the PEER intervention feasible and acceptable for the peer coaches who deliver the intervention?
3. Do intervention recipients show a higher level of quality of life at immediate, 4-week, and 8-week post-intervention?
4. Do intervention recipients display increases in measures of psycho-social-spiritual well-being at immediate, 4-week, and 8-week post-intervention? Peer coach participants will a) take training sessions, b) deliver 5 coaching sessions to an intervention recipient participant, c) complete surveys before training, after training, and after intervention delivery, and d) participate in a personal interview Intervention recipient participants will a) attend 5 coaching sessions delivered by a peer coach participant, b) complete surveys before intervention, immediately post intervention, 4-week post intervention, and 8 week post-intervention, and c) participate in a personal interview.

Eligibility

Sex
ALL
Min age
21 Years
Max age
99 Years
Healthy volunteers
No
Inclusion criteria for peer coach: * Aged 21 years and above * Diagnosed with stroke within the past 5 years and discharged from the hospital Inclusion criteria for intervention recipients * Aged 21 years and above * Diagnosed with stroke within the past 1 year and discharged from the hospital Exclusion criteria for all participants: * Unable to communicate in English * Unable to provide informed consent * Diagnosed with one or multiple conditions which affect cognitive and/or mental health severely * Diagnosed with severe or potentially terminal co-morbidities

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanyang Technological University Singapore Singapore Recruiting

More Nanyang Technological University trials in Singapore

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07463014 on ClinicalTrials.gov ↗ ← All trials in Singapore